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Abstract 
Metastatic melanoma remains incurable, emphasising the acute need for improved 
research models to investigate the underlying biological mechanisms mediating 
tumour invasion and metastasis, and to develop more effective targeted therapies to 
improve clinical outcome. Available animal models of melanoma do not accurately 
reflect human disease and current in vitro human skin equivalent models 
incorporating melanoma cells are not fully representative of the human skin 
microenvironment. 
We have developed a robust and reproducible, fully-humanised 3D skin equivalent 
comprising a stratified, terminally differentiated epidermis and a dermal compartment 
consisting of fibroblast-generated extracellular matrix. Melanoma cells incorporated 
into the epidermis were able to invade through the basement membrane and into the 
dermis, mirroring early tumour invasion in vivo. 
Comparison of our novel 3D melanoma skin equivalent with melanoma in situ and 
metastatic melanoma indicates this model accurately recreates features of disease 
pathology, making it a physiologically representative model of early radial and 
vertical growth phase melanoma invasion. 
 
Introduction 
Cutaneous metastatic melanoma remains one of the most deadly forms of cancer, 
with a rapidly increasing incidence, mortality and public health burden. Although 
early stage melanoma is largely curable through surgical resection, continued 5-year 
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survival rates of only 5-19% for advanced disease (1) reflect the lack of consistently 
beneficial treatments for metastatic melanoma. Improved research models are 
therefore urgently needed to investigate the underlying biological mechanisms 
mediating tumour invasion and subsequent metastasis, and to facilitate the 
development of more effective targeted therapies to improve clinical outcome. 
Human skin comprises an upper epidermal layer containing mainly keratinocytes in 
close association with melanocytes, and a lower dermal layer containing multiple cell 
types including fibroblasts that synthesise extracellular matrix (ECM) components to 
support cellular growth (2). Keratinocytes form a proliferative basal layer and 
differentiate as they move towards the surface of the skin, while melanocytes, the 
precursor cells of melanoma, proliferate less frequently and remain at the epidermal-
dermal junction where they interact with basal layer keratinocytes to regulate tanning 
of the skin in response to UV radiation (3). A basement membrane, composed of 
matrix molecules including laminin isoforms and type IV, VII and XVII collagens 
separate melanocytes and keratinocytes from the papillary dermis (4). However, 
when melanocytes become transformed, hyper-proliferative and migratory 
melanoma cells invade through the basement membrane into the dermis. Therefore 
models that aim to investigate early melanoma development must recreate the 
microenvironment of this distinct cellular niche (5). 
While mouse xenograft models of melanoma in immunocompromised mice are 
commonly used to investigate tumour development, progression and therapeutic 
response they do not accurately recreate the microenvironment of human melanoma 
at either the primary or distant site. As such, these models cannot recapitulate the 
initial events leading to early invasion through the basement membrane or 
dissemination of melanoma cells throughout the skin and to subsequent metastatic 
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sites. Furthermore, while spontaneous mouse melanoma models (6-8) are useful for 
investigating the early stages of mouse melanoma development, significant 
differences between the architecture of human and rodent skin (9), as well as 
differences observed in the histopathological features of human and murine 
melanoma subtypes (10) make it difficult to extrapolate results from these studies 
into a clinically relevant context. 
To more accurately investigate early stage human melanoma, full-thickness in vitro 
skin equivalent models incorporating melanoma cells have been developed, which 
allow investigation of melanoma migration and invasion from the epidermis into the 
dermis (11-14). However, such equivalents comprise a dermal component created 
from fibroblasts embedded in bovine or rat-tail collagen, which as well as contracting 
over time leading to distortion and disruption of the equivalent, are not representative 
of the normal human skin microenvironment as they include non-human ECM 
components. Alternatively, while de-cellularised human skin models offer a human 
skin microenvironment, variability between donors results in inconsistent melanoma 
migration, which impacts the reproducibility of these assays (15). 
The present study describes a novel in vitro model for the investigation of early 
melanoma invasion, such as that which occurs in radial and vertical growth phase 
melanoma, within a fully-humanised cutaneous microenvironment. We have 
developed a unique full-thickness three dimensional (3D) skin equivalent 
(organotypic skin culture) through the incorporation of an inert porous scaffold (16) 
with appropriate pore sizes to support the 3D growth and cell-cell contact of primary 
human dermal fibroblasts. Fibroblasts are stimulated to produce their own ECM 
constituents (17, 18), forming a stable dermal component that is physiologically 
representative of normal human skin. Following addition of primary human 
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keratinocytes, crosstalk between fibroblasts and keratinocytes facilitates the 
development of a permissive microenvironment conducive to long-term culture (19). 
This is consistent with previous studies showing the stratum corneum of skin 
equivalents formed on fibroblast-derived matrix contains a considerably higher 
concentration of natural moisturising factor compared to animal collagen based skin 
equivalents, thus allowing cultures to be maintained for up to 20 weeks (20). 
Seeding melanoma cells onto the dermal equivalent prior to the incorporation of 
primary human keratinocytes, rather than implanting melanoma spheroids directly 
into the dermis (21), or suspending melanoma cells in hydrogel (22), places the 
melanoma cells in their original micro-environmental niche within the skin, resulting 
in subsequent proliferation and nest formation at the epidermal-dermal junction prior 
to invasion through the basement membrane. We demonstrate that active invasion 
of melanoma cells results in breakdown of basement membrane components type IV 
and VII collagens, accurately recapitulating the pattern of early melanoma invasion 
observed in human cutaneous tumours in vivo, thus providing a valuable tool to 
investigate mechanisms mediating melanoma initiation and early stages of disease 
progression. 
 
Materials and Methods 
Cell culture 
Primary human neonatal foreskin fibroblasts (CellnTec; Stauffcherstr, Switzerland) 
were cultured in Media A (Table 1) for up to 7 passages. Immortalised mouse 
embryonic 3T3 fibroblasts (ATCC-CCL-92) were cultured in Media D. Following 
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informed consent, primary human keratinocytes derived from surplus skin obtained 
from patients (aged between 20 and 55) undergoing routine surgery (for which full 
ethical approval was obtained; National Research Ethics reference, Newcastle and 
North Tyneside 1 08/H0906195 for all studies with human tissue) were isolated by 
incubating the skin in dispase (Scientific Laboratory Supplies, Nottingham, UK) for 
12-18 h at 4oC to separate the epidermis from the dermis before dissociating the 
epidermis with trypsin/EDTA (Scientific Laboratory Supplies) (23) for 5 min at 37oC 
and subsequently cultured in Media E for up to 2 passages. Keratinocytes were then 
further co-cultured with mitomycin C (Sigma-Aldrich, Poole, UK) treated 3T3 feeder 
cells (24) at 1:1 ratio in Media B (based on (25)) for up to 3 passages, changing the 
media every day. Following detachment with trypsin/EDTA, keratinocytes were 
subsequently incubated with an equal volume of soybean trypsin inhibitor (Sigma-
Aldrich) and centrifuged at 300 g for 5 min prior to re-suspension in fresh culture 
media and subsequent culture. Human metastatic melanoma cell line, SK-mel-28 
(LGC Standards; ATCC-HTB-72,) and the primary human melanoma cell line, WM35 
(Coriell Cell Repositories, Philadelphia) were obtained in 2011, and are tested every 
6 months for Melan-A expression by immunofluorescence, with BRAF mutational 
status confirmed by real time polymerase chain reaction (26), and cultured in Media 
A as previously described (27). All cells were cultured at 37oC in a humidified 
atmosphere with 5% CO2 in air. 
Human skin equivalent preparation  
12-well format Alvetex® scaffold (Reinnervate Ltd, Reprocell group) were pre-treated 
with 70% ethanol in a 6-well plate according to the manufacturer’s instructions. 2.0 x 
106 primary human neonatal foreskin fibroblasts were seeded onto Alvetex® in 100 l 
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Media A and incubated at 37oC, in a humidified atmosphere of 5% CO2 in air for 1.5 
hours. 9 ml of Media A + 100 g/ml ascorbic acid (Sigma-Aldrich) were subsequently 
applied to the bottom of each well to gently flood the insert prior to incubation for a 
further 18 days, changing media every 3.5 days, to allow the formation of a dermal 
equivalent. Dermal equivalents were subsequently washed with 10 ml phosphate 
buffered saline (PBS; Sigma-Aldrich) prior to the addition of 4 ml Media B to the 
outer side of the insert such that the bottom of each dermal equivalent was in contact 
with the media. To establish a melanoma 3D equivalent, 2.0 x 104 melanoma cells 
were applied to the dermal equivalent in 100 l Media B and incubation at 37oC 
continued for a further 3 hours. In the meantime, primary human keratinocytes were 
harvested by differential trypsinisation, discarding the 3T3 feeder cells, and 2.0 x 106 
keratinocytes seeded onto dermal equivalents (with or without melanoma cells) in 
100 l Media B and incubation continued for a further 3 hours. 5ml of Media B was 
then applied to the outer side of each well to gently flood the inside of the insert prior 
to further incubation at 37oC for 3 days, changing the media every day. On day 21, 
the insert was removed from the 6-well plate and placed into a well insert holder in a 
deep petri dish (Reinnervate Ltd, Reprocell group) on the middle rung of the stand. 
30 ml of Media C was then added to the dish such that the bottom of the equivalent 
was in contact with the media but the upper surface remained exposed to the air and 
incubation continued at 37oC in 5% CO2 for 14 days, changing the media every 3.5 
days, to allow the formation of a full-thickness skin equivalent. 
Scanning electronmicroscopy (SEM) 
Skin equivalent or primary tissue samples of normal human skin were fixed in a 1:1 
mix of DMEM media and double strength fixation buffer (16% PFA (Sigma-Aldrich), 
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25% glutaraldehyde (Agar Scientific, Stansted, UK), 0.2 M sodium cacodylate (Agar 
Scientific)) for 5-10 mins at room temperature. Samples were then transferred to a 
new tube and incubated in single strength fixation buffer (8% PFA, 12.5% 
glutaraldehyde, 0.1 M sodium cacodylate) at 4oC for 1 hour prior to washing in PBS 
three time for 5 minutes each. Samples were subsequently cut into 2-3 mm2 squares 
and immersed in post-fixation buffer (1% osmium tetroxide (Agar Scientific)) in 0.1M 
sodium cacodylate) at 4oC for 60 minutes before washin in 0.1M sodium cacodylate 
buffer twice for 10 minutes each. Following dehydration though a series of ethanol 
washes (30%, 50%, 70%, 80%, 90%, 95% and 100%) each for 15 minutes, samples 
were then dried using a critical point dryer (Baltec CPD030, Pfäffikon ZH, 
Switzerland), coated in 5 nm of platinum using a Cressington Coating System 328 
(Cressington Scientific Instruments, Watford, UK) and visualised using a Leica 
S5200 scanning electron microscope (Leica Microsystems, Milton Keynes, UK). 
Immunofluorescent analysis of skin biomarkers 
Formalin-fixed, paraffin-embedded primary human tissue samples derived from an in 
situ melanoma or an AJCC stage IV metastatic melanoma were used as a 
comparative to 3D human melanoma skin equivalents. All samples were processed 
for haematoxylin and eosin staining or immunohistochemistry as previously 
described (28, 29). 5 M sections were incubated with 1:1000 mouse anti-human 
type III collagen (kindly supplied by Dr Rachel Watson, Manchester University) 
(Abcam, Cambridge, UK; ab23445), 1:1000 mouse anti-type IV collagen (Abcam; 
ab6586), 1:400 rabbit anti-type VII collagen (kindly supplied by Dr Mei Chen (30)), 
1:1000 rabbit anti-cytokeratin 1 (Abcam; ab93652), 1:1000 mouse anti-cytokeratin 14 
(Abcam; ab7800), 1:1000 mouse anti-involucrin (Abcam; ab68), or 1:250 mouse anti-
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Melan-A (Abcam; ab731) primary antibodies diluted in PBS + 5% BSA overnight at 
4oC. Primary antibody binding was detected with secondary Alexa Fluor 488 goat 
anti-mouse (Life Technologies, Paisley, UK) or Alexa Fluor 488 goat anti-rabbit 
antibodies (Life Technologies) and cell nuclei counter stained with DAPI (1 g/ml; 
Life Technologies) diluted in PBS + 5% BSA for 1 hour at room temperature. 
Sections were finally mounted under glass coverslips in Vectorshield mounting 
media (Vector Laboratories, Peterborough, UK) and visualised using either a Leica 
DMI3000B (Leica Microsystems) or an Axioimager Z2 (Carl Zeiss Ltd, Cambridge, 
UK). 
 
Results  
Generation of a full-thickness human skin equivalent  
Alvetex® porous polymer scaffolds were used to create a full-thickness human skin 
equivalent in the absence of any animal matrix components (Figure 1). Pre-treatment 
of Alvetex® by immersion in 70% ethanol rendered it hydrophilic allowing media and 
cells to enter the 3D matrix. Alvetex® scaffolds were subsequently washed with 
culture media to remove the ethanol and seeded with primary human neonatal 
foreskin fibroblasts, prior to culture for 18 days in Media A (Table 1) supplemented 
with ascorbic acid to promote synthesis of collagen polypeptides through the 
processing of pro-collagens to collagen α-chains (17). Primary human keratinocytes 
isolated from the epidermis of normal human skin were then seeded onto the upper 
surface and cultured for 3 days in Media B. The upper surface was subsequently 
exposed at the air/liquid interface for 14 days to induce keratinocyte differentiation, 
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while the lower surface remained in contact with Media C, resulting in the formation 
of a full-thickness human skin equivalent. 
Cell numbers, media components and time intervals for each step of the protocol 
were optimised to allow full scaffold colonisation by dermal fibroblasts (Figure 2a) 
and the establishment of an intact, fully stratified epidermis with key morphological 
features of a stratum basale, stratum spinosum and stratum corneum (Figure 2b, 20x 
magnification; Figure 2c, 10x magnification). Electron micrographs indicate the 
structure and porosity of the Alvetex® scaffold membrane (Figure 2d) supporting 
fibroblast growth in three dimensions and facilitating the establishment of a full-
thickness human skin equivalent (Figure 2e) with clear morphological similarities to 
normal human skin (Figure 2f). 
Primary human keratinocytes and fibroblasts in organotypic culture form a 
humanised skin microenvironment 
Normal human skin comprises a dermal layer and a multi-layered epidermis, each 
layer of which displays a distinct protein expression profile (Figure 3a). The dermis 
contains extracellular matrix components, including type I and III collagen, while the 
epidermis is characterised by the expression of various cytokeratins that are 
differentially regulated within different layers of the epidermis, reflecting the 
progressive stages of normal human keratinocyte differentiation. Histological 
analysis of our established 3D skin equivalent (Figure 3b) demonstrated 
morphological similarities to that of normal human skin (Figure 3c), and a 
comparative commercially available model (Mattek EpidermFT; Figure 3d); in 
particular the presence of a fully developed stratum corneum was evident indicating 
keratinocyte differentiation and barrier formation. 
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Immunofluorescent staining also revealed the expression of human type III, IV and 
VII collagen, cytokeratin 1 and 14 as well as involucrin (Figure 3), to varying degrees 
in the 3D skin equivalent, normal human skin and the Mattek EpidermFT.  Dermal 
fibroblasts contained within the 3D skin equivalent for 35 days clearly expressed type 
III collagen (Figure 3t), which albeit not as abundant as expression observed in 
normal human skin (Figure 3u) nevertheless indicated the production of human 
extrcellular matrix, critical to the long-term maintenance of the skin equivalent. In 
contrast however, less human type III collagen expression was observed in the 
Mattek EpidermFT (Figure 3v), likely due to their construction mainly being based on 
the use of bovine type I collagen that may suppresses further ECM production by the 
dermal fibroblasts. The 3D skin equivalent model also demonstrated production of 
human type I collagen (data not shown). 
The basement membrane components type IV and VII collagens were clearly 
expressed at the epidermal-dermal junction of both the 3D skin equivalent (Figure 
3n,q) and normal human skin (Figure 3o,r), indicating interaction between fibroblasts 
and keratinocytes and synthesis of a de novo basement membrane. However, while 
expression of type IV collagen was partially observed between the epidermal and 
dermal layers within the Mattek EpidermFT model, there was no evidence for the 
organised expression of type VII collagen (Figure 3p,s). It is possible however, that 
the Mattek EpidermFT model may not have been cultured for sufficient time to 
enable type VII collagen organisation and the formation of a basement membrane 
comparable  to normal skin (31).   
Expression of cytokeratin 14 by keratinocytes within the 3D skin equivalent also 
indicated the formation of a stratum basale (Figure 3k), resembling that of normal 
human skin (Figure 3l). Keratinocytes within the 3D skin equivalent appeared to 
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undergo normal differentiation as demonstrated by the expression of cytokeratin 1 
and involucrin in suprabasal and terminal layer keratinocytes, indicative of stratum 
spinosum and stratum granulosum formation respectively (Figure 3h,e), and again 
indicative of the pattern of epidermal differentiation observed in normal human skin 
(Figure 3i,f). Furthermore, while expression of cytokeratin 14 (Figure 3m) was 
observed in Mattek EpidermFT, cytokeratin I (Figure 3j) and involucrin (Figure 3g) 
expression was less well defined, indicating formation of a stratum basale but 
ineffective keratinocyte differentiation in this model. The establishment of an 
organotypic skin equivalent on Alvetex® scaffolds therefore accurately recreates the 
microenvironment of normal human skin. This was subsequently used to investigate 
melanoma cell behaviour in vitro.  
Melanoma cell invasion through the basement membrane of fully humanised 
3D skin equivalents recreates the progressive histopathological features of 
melanoma invasion in human skin 
The potential for human melanoma cell lines derived from either primary or 
metastatic tumours to invade the pore structure of Alvetex® scaffolds was verified in 
the absence of primary fibroblasts (data not shown). To model melanoma invasion, 
metastatic melanoma cells were applied to pre-established fibroblast-containing 
Alvetex® dermal equivalents prior to the incorporation of keratinocytes at a slightly 
lower ratio (100:1) to the physiological ratio of keratinocytes to melanocytes in 
normal human skin (36:1) (32), in order to prevent tumour cell over growth within the 
epidermis prior to the observation of dermal invasion. Histological staining of a 3D 
skin equivalent 2 weeks post-incorporation with metastatic SK-mel-28 melanoma 
cells demonstrated the development of melanoma nests at the epidermal/dermal 
junction (Figure 4a), verified by the expression of the melanocyte lineage-specific 
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marker Melan-A (Figure 4e). Immunofluorescent staining for the human basement 
membrane components type IV collagen (Figure 4i) and type VII collagen (Figure 5a) 
2 weeks after the incorporation of melanoma cells into the skin equivalent revealed 
intact expression of both markers and clear localisation of melanoma cells above 
both type IV (Figure 4m,q) and type VII collagen (Figure 5e,i). However, culture for a 
further 2 weeks resulted in the invasion of Melan-A-positive melanoma cells into the 
dermal component (Figure 4b,f), accompanied by disruption of type IV collagen 
(Figure 4j) and loss of type VII collagen (Figure 5b). Furthermore, co-staining for 
Melan-A and either type IV collagen (Figure 4n,r) or type VII collagen (Figure 5f,j) 
demonstrated disruption of these basement membrane components coincided with 
melanoma invasion, indicating SK-mel-28 melanoma cells actively invade from the 
epidermis into the dermis of the skin equivalent through the basement membrane. 
Similar results were also obtained with skin equivalents incorporating Melan-A-
positive primary WM35 melanoma cells, where again tumour invasion through the 
basement membrane, albeit less than metastatic SK-mel-28, was observed with a 
concurrent disruption of type IV collagen at 4 weeks (Supplementary Figure 1). 
To validate whether invasion of melanoma cells within a 3D skin equivalent 
accurately reflects the progressive stages of clinical disease, the effect of melanoma 
cells on type IV and VII collagen were investigated in a formalin-fixed paraffin 
embedded in situ melanoma or in a primary tumour derived from a patient with 
metastatic disease. Histological staining and Melan-A immunostaining of the 
melanoma in situ (Figure 4c,g) confirmed a minimally invasive tumour accompanied 
by continuous and intact expression of both type IV (Figure 4k) and type VII collagen 
(Figure 5c) at the epidermal/dermal junction. Co-immunostaining demonstrated that 
in pre-invasive melanomas, cells are located above type IV (Figure 4o,s) and type 
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VII collagen (Figure 5g,k) indicating an intact basement membrane, which reflects 
the histopathological features observed in 3D skin equivalents after 2 weeks post-
incorporation with melanoma cells. Conversely, histology and immunostaining for the 
expression of Melan-A in the metastatic melanoma (Figure 4d,h) revealed highly 
invasive tumour cells with disrupted type IV (Figure 4l) and VII collagen (Figure 5d) 
expression. Active invasion of this advanced metastatic melanoma, resulting in loss 
or disruption of type IV collagen (Figure 4p,t) and type VII collagen (Figure 5h,l), 
similarly reflected the histopathological features observed in 3D skin equivalents 4 
weeks after incorporation of SK-mel-28 metastatic melanoma cells. Collectively, 
these data indicate our novel 3D skin equivalent accurately recreates the 
progressive histopathological features of melanoma invasion in human skin and the 
applicability of this novel organotypic skin model as a valuable tool for the 
investigation of early melanoma invasion. 
 
Discussion 
The present study demonstrates the generation of a novel full-thickness human skin 
equivalent bearing morphological and structural similarity to normal human skin 
within 35 days. We have optimised and validated a protocol for the construction of an 
organotypic skin model from primary human fibroblasts and keratinocytes that 
accurately recreates the microenvironment of normal human skin, as demonstrated 
by the production of human extracellular matrix component type III collagen, as well 
as the distinct expression profile of basement membrane proteins type IV and VII 
collagen, and epidermal differentiation markers cytokeratin 14, and involucrin. 
Incorporation of melanoma cells into their original environmental niche at the 
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epidermal/dermal junction demonstrates tumour cells retain their proliferative and 
invasive potential, forming melanoma clusters before invading though the basement 
membrane into the dermis. 
Comparative histopathological features observed in primary melanomas derived 
from differing American Joint Committee on Cancer (AJCC) disease stages (33), 
confirm the 3D skin equivalent model is physiologically representative of clinical 
disease. Conversely, while Mattek EpidermFT expressed type IV collagen, the lack 
of human type III and VII collagen expression suggests the reduced longevity of this 
model will limit its use for the investigation of less invasive melanoma cells. 
Interestingly, our data demonstrate that while invasion of both SK-mel-28 and WM35 
melanoma cells through the basement membrane of the 3D skin equivalent resulted 
in the breakdown and disruption of type IV collagen there appeared to be an 
increase in type IV collagen surrounding invading tumour cells, consistent with 
previous observations showing increased type IV collagen expression parallels 
melanoma progression (34, 35) and which is directly required for melanoma 
metastasis (36). However, increased type IV collagen in this context is likely 
independent of its function as a basement membrane component as it does not form 
a continuous membrane structure. Collectively these data support the validity of the 
3D skin equivalent as a representative model of early melanoma invasion in vivo.  
Furthermore, since chemokines and growth factors including IGF-1 (37) are known 
to drive melanoma invasion, the present model may also offer a means through 
which to study the effect of modulating such factors within melanoma cells on early 
tumour invasion.  
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In addition to confirming the presence of distinct skin layers within the skin 
equivalent, our data demonstrate the presence of regular compacted areas within 
the epidermis (Figure 2b), which may represent important microenvironmental niche 
areas of the skin where skin stem cells may reside (38-41). Importantly these data 
confer the additional potential utility of our 3D skin equivalent model for the 
investigation of dermal stem cell and hair follicle biology. 
Furthermore, while the model presented is an allogeneic skin equivalent specifically 
developed for the investigation of melanoma invasion, it may be readily adapted into 
an autologous setting for the investigation of immunological pathologies, or adapted 
through the addition of endothelial cells to the lower surface for studies of 
angiogenesis within the skin or development of tumour neovasculature. Grafting the 
3D skin equivalent onto immunocompromised mice, in line with studies in alternative 
skin equivalent models (42), may also represent a useful means through which to 
investigate tumour cell dissemination from the skin to secondary sites. 
In summary, the 3D skin equivalent model presented represents a robust and 
reproducible assay that is widely applicable to dermatological research, mimicking 
the morphology and microenvironment of normal human skin more accurately than 
previous assays. The demonstration of the applicability of this model for the 
investigation of the early stages of human melanoma invasion therefore renders it a 
valuable tool for defining and evaluating urgently required novel drug targets and 
personalised therapies. 
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Figure legends 
Figure 1: Schematic protocol for the formation of full-thickness human skin 
equivalents. Pretreat inert Alvetex® polymer scaffold in 70% ethanol before 
thoroughly washing in Media A, then seed with 5.0 x 105 human dermal fibroblasts. 
Culture fibroblast-seeded Alvetex® in Media A for 18 days to create a dermal 
equivalent. If establishing a melanoma full thickness skin equivalent, seed 2.0 x 104 
metastatic melanoma cells onto the dermal equivalent and culture in Media B for 3 
hours prior to the addition of primary human keratinocytes. Alternatively, to create a 
full thickness skin equivalent, add 2.0 x 106 keratinocytes directly onto the dermal 
equivalent. Culture the (melanoma) equivalent fully submerged in Media B for 3 days 
before exposing the upper surface of the equivalent to the air–liquid interphase and 
continuing culture for 14 days with the lower surface in contact with Media C (See 
methods for full protocol). 
Figure 2: Validation of dermal and epidermal structure in full-thickness human 
skin equivalents. a) Representative photomicrographs of haematoxylin and eosin 
(H&E) stained Alvetex® seeded with human dermal fibroblasts after culture in Media 
A for 18 days. b&c) Representative photomicrographs showing H&E stained 35 day 
full-thickness human skin equivalents at 20x and 10x magnification respectively. d) 
Representative electronmicrographs of a non-cellularised Alvetex® scaffold, e) 35 
day full-thickness human skin equivalent or f) normal human skin. a-c scale bars, 
100 m; d-f scale bars, 75 m; Epi, epidermis; Der, dermis. 
Figure 3: Expression of epidermal, dermal or basement membrane markers in 
full-thickness human skin equivalents compared to human skin and Mattek 
EpiDermFT. a) Schematic illustrating dermal and epidermal protein marker 
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expression. b-d) Representative photomicrographs showing an H&E stained full-
thickness human skin equivalent (b), normal human skin (c) or  a  Mattek EpiDermFT 
(d). e) Representative fluorescent photomicrographs for the expression of  involucrin 
(e-g), cytokeratin I (CK 1, h-j), cytokeratin XIV (CK 14, k-m), type IV collagen (n-p), 
type VII collagen (q-r) or type III collagen (t-v) in full-thickness human skin 
equivalents, normal human skin or Mattek EpiDermFT. b-d & t-v scale bars, 75 m; 
e-s scale bars, 25 m.  
Figure 4: Early cutaneous melanoma invasion in full-thickness human skin 
equivalents results in disruption of basement membrane component type IV 
collagen. Representative photomicrographs showing H&E stained full thickness 
melanoma skin equivalents (MSE) at 2 weeks (a) or 4 weeks (b) post-inoculation 
with melanoma cells, highlighting clusters/nests of melanoma cells at the 
dermal/epidermal junction at week 2, which subsequently invade through the 
basement membrane at week 4 (black arrow heads); and H&E stained sections of a 
melanoma in situ (c) or a primary superficial spreading malignant melanoma (d; 
invasive melanoma) (black dotted lines illustrate the tumour boundary). 
Representative fluorescent photomicrographs for the expression of Melan-A (red; e-
h) or type IV collagen (green; i-l) in 2 week (e and i) or 4 week (f and j) MSEs, 
melanoma in situ (g and k), or an invasive melanoma (h and l) (Red arrows illustrate 
intact type IV collagen while white arrows illustrate where type IV collagen is lost). m-
p) Overlay fluorescent photomicrographs showing relative expression of Melan-A 
and type IV collagen in 2 week (m) and 4 week (n) MSEs, melanoma in situ (o), and 
an invasive melanoma (p; note melanoma cells have invaded from right to left) with 
white boxes highlighting area magnified in panels q-t (blue = DAPI). q-t) 63x 
magnification of Melan-A and type IV collagen in 2 week (q) and 4 week (r) MSEs, 
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melanoma in situ (s), and an invasive melanoma (t). a-p scale bars, 100 m; q-t 
scale bars, 25 m. 
Figure 5: Early cutaneous melanoma invasion in full-thickness human skin 
equivalent results in disruption of basement membrane component type VII 
collagen. a-d) Representative fluorescence photomicrographs of type VII collagen 
(green) expression in 2 week (a) and 4 week (b) melanoma skin equivalents (MSE), 
melanoma in situ (c), and a primary superficial spreading malignant melanoma (d; 
invasive melanoma). e-h) Overlay fluorescence photomicrographs showing relative 
expression of Melan-A (red) and type VII collagen in 2 week (e) and 4 week (f) 
MSEs, melanoma in situ (g) and an invasive melanoma (h) with white boxes 
highlighting area magnified in panels i-l (blue = DAPI). i-l) 63x magnification of 
Melan-A and type VII collagen in 2 week (i) and 4 week (j) MSEs, melanoma in situ 
(k), and an invasive melanoma (l). a-h scale bars, 100 m; i-l scale bars, 25 m. 
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Supplementary Figure Legends 
Supplementary Figure 1: Early cutaneous invasion of WM35 melanoma cells in 
full-thickness human skin equivalents results in disruption of basement 
membrane component type IV collagen. Representative fluorescent 
photomicrographs for the expression of Melan-A (red; a and b) or type IV collagen 
(green; c and d) and overlay images (e and f) in 2 week (a, c and e) or 4 week (b, d 
and f) MSEs containing the melanoma cell line WM35 derived from a primary radial 
growth phase melanoma. Scale bars, 100 m.  
 

